DE3468413D1 - Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide against platelet aggregation - Google Patents

Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide against platelet aggregation

Info

Publication number
DE3468413D1
DE3468413D1 DE8484401564T DE3468413T DE3468413D1 DE 3468413 D1 DE3468413 D1 DE 3468413D1 DE 8484401564 T DE8484401564 T DE 8484401564T DE 3468413 T DE3468413 T DE 3468413T DE 3468413 D1 DE3468413 D1 DE 3468413D1
Authority
DE
Germany
Prior art keywords
pyrrolidinylmethyl
allyl
methoxy
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484401564T
Other languages
English (en)
Inventor
Andre Debay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Application granted granted Critical
Publication of DE3468413D1 publication Critical patent/DE3468413D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8484401564T 1983-08-10 1984-07-26 Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide against platelet aggregation Expired DE3468413D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313141A FR2550447B1 (fr) 1983-08-10 1983-08-10 Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire

Publications (1)

Publication Number Publication Date
DE3468413D1 true DE3468413D1 (en) 1988-02-11

Family

ID=9291535

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19843426154 Withdrawn DE3426154A1 (de) 1983-08-10 1984-07-16 Verwendung von n-(1-allyl-2-pyrrolidinylmethyl) -2-methoxy-4-amino-5-methylsulfamoyl-benzamid
DE8484401564T Expired DE3468413D1 (en) 1983-08-10 1984-07-26 Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide against platelet aggregation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19843426154 Withdrawn DE3426154A1 (de) 1983-08-10 1984-07-16 Verwendung von n-(1-allyl-2-pyrrolidinylmethyl) -2-methoxy-4-amino-5-methylsulfamoyl-benzamid

Country Status (7)

Country Link
US (1) US4607047A (de)
EP (1) EP0133830B1 (de)
JP (1) JPS6056919A (de)
AT (1) ATE31717T1 (de)
DE (2) DE3426154A1 (de)
FR (1) FR2550447B1 (de)
IT (1) IT1181824B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2713933B2 (ja) * 1987-12-29 1998-02-16 松下電器産業株式会社 密閉型圧縮機
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
KR19990071666A (ko) * 1995-11-30 1999-09-27 이경하 술파미드 유도체
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358892A1 (fr) * 1976-07-19 1978-02-17 Ile De France N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
US4263316A (en) * 1978-10-11 1981-04-21 Societe D'etudes Scientifiques Et Industrielles De L'ile De France N-(1-Methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy-5-methylsulfamoyl benzamide and its derivatives, methods of preparing them and their application to the treatment of troubles of the lower part of the body
FR2489327B1 (fr) * 1980-08-28 1984-05-18 Ile De France N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament

Also Published As

Publication number Publication date
FR2550447B1 (fr) 1986-01-17
JPH0447650B2 (de) 1992-08-04
FR2550447A1 (fr) 1985-02-15
IT1181824B (it) 1987-09-30
IT8448700A1 (it) 1986-02-07
EP0133830A1 (de) 1985-03-06
US4607047A (en) 1986-08-19
JPS6056919A (ja) 1985-04-02
IT8448700A0 (it) 1984-08-07
EP0133830B1 (de) 1988-01-07
ATE31717T1 (de) 1988-01-15
DE3426154A1 (de) 1985-02-21

Similar Documents

Publication Publication Date Title
DE3476964D1 (en) Cuff equipment for, inter alia, achieving and maintaining fluid- and gas-depleted regions in parts of the body
AU530999B2 (en) Substituted amino triazines and their use in treatment of cns disorders
GR3000562T3 (en) N-(2'-aminophenyl)-benzamide derivatives, process for their manufacture and their application in the treatment of neoplastic illness
GR80171B (en) N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
ES532475A0 (es) Procedimiento para la produccion de n-(5-nitropirimidinil)-n'-sulfonilureas
TR22082A (tr) Polimerizasyon dereceli buten-1'in istihsali icin usul
IT8620298A0 (it) Sali di diacetilreina e loro impiego terapeutico nel trattamento dell'artrosi.
SG30593G (en) Use of the agent azelastine in the treatment of psoriasis
PH27413A (en) 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasopastic
IT1198039B (it) Procedimento e dispositivo per comandare una disposizione per l'arresto dello stoppino in un filatoio
DE3468413D1 (en) Use of n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide against platelet aggregation
GR80724B (en) Pharmacologically active ketones and use
PH25019A (en) New benzamides and their use in treating gastrointestinal disorders
PH14572A (en) 2-bromo-6-fluoro-n-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension
GB1539862A (en) N-(acyl)-p-amino-n'-(monosubstituted)benzamide anti-ulcer agents
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
IT1161943B (it) Procedimento e dispositivo per unire due estremita' di filato mediante impiombatura
EP0114048A3 (en) Use of d,l and d-carazolole as an antiglaucoma agent, and pharmaceutical compositions containing them
EG15911A (en) Method for treating cardiac disorders with n-(aryloxyalkyl)-n'-(aminoalkyl)ureas
IT1157918B (it) Meptazinolo e suoi sali di addizione con acidi per l'impiego nel trattamento dello shock
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
DE3465305D1 (en) 2-tolyl-morpholine derivatives for therapeutical use
FR2546397B1 (fr) Perfectionnements aux dispositifs pour la prise d'occlusion chez l'edente total haut et bas
IT8468188A1 (it) Apparecchiatura e procedimento per ritardare le perdite di lubrificante in una macchina per cucire.
JO1041B1 (en) N- (1-methyl-2-pyrrolidinyl-methyl) -3,2-dimethoxy-5-methyl sulfamoyl benzamide and its derivatives, methods of preparation and use in treatment of disorders of the lower part of the urethra

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee